Your browser doesn't support javascript.
loading
Lenalidomide and dexamethasone in treatment of patients with relapsed and refractory multiple myeloma - analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies.
Maisnar, V; Stefanikova, Z; Spicka, I; Pour, L; Minarik, J; Flochova, E; Radocha, J; Gregora, E; Stecova, N; Jelinek, T; Jungova, A; Kralikova, E; Brozova, L; Hajek, R.
Afiliación
  • Maisnar V; 4th Department of Medicine - Hematology, Faculty Hospital and Charles University, Hradec Kralove, Czech Republic.
  • Stefanikova Z; Department of Clinical Hematology, University Hospital and Comenius University, Bratislava, Slovakia.
  • Spicka I; 1st Department of Medicine - Clinical Department of Hematology, First Faculty of Medicine and General Teaching Hospital, Charles University, Prague, Czech Republic.
  • Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Minarik J; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
  • Flochova E; Department of Hematology and Transfusiology, University Hospital and Comenius University, Martin, Slovakia.
  • Radocha J; 4th Department of Medicine - Hematology, Faculty Hospital and Charles University, Hradec Kralove, Czech Republic.
  • Gregora E; Department of Internal Medicine and Hematology, 3rd Faculty of Medicine, Charles University and Faculty Hospital Kralovske Vinohrady, Prague, Czech Republic.
  • Stecova N; Department of Hematology and Transfusiology, Luis Pasteur University Hospital, Kosice, Slovakia.
  • Jelinek T; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine University of Ostrava, Ostrava, Czech Republic.
  • Jungova A; Hematology and Oncology Department, Charles University Hospital Pilsen, Plzen, Czech Republic.
  • Kralikova E; Department of Hematology and Transfusiology, F. D. Roosevelt Faculty Hospital, Banska Bystrica, Slovakia.
  • Brozova L; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Hajek R; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine University of Ostrava, Ostrava, Czech Republic.
Neoplasma ; 66(3): 499-505, 2019 May 23.
Article en En | MEDLINE | ID: mdl-30784289
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_lymphomas_multiple_myeloma Asunto principal: Dexametasona / Sistema de Registros / Lenalidomida / Mieloma Múltiple Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Neoplasma Año: 2019 Tipo del documento: Article País de afiliación: República Checa
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_lymphomas_multiple_myeloma Asunto principal: Dexametasona / Sistema de Registros / Lenalidomida / Mieloma Múltiple Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Neoplasma Año: 2019 Tipo del documento: Article País de afiliación: República Checa